Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?

J Med Microbiol. 2008 Aug;57(Pt 8):1046-1048. doi: 10.1099/jmm.0.47822-0.

Authors

Tamilarasu Kadhiravan¹, Naveet Wig¹, K Renuka², Arti Kapil², Sushil K Kabra³, Anoop Misra¹

Affiliations

¹ Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
² Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
³ Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.

PMID: 18628512
DOI: 10.1099/jmm.0.47822-0

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Anti-Infective Agents / pharmacology
Anti-Infective Agents / therapeutic use
Drug Resistance, Bacterial
Female
Humans
Male
Nalidixic Acid / pharmacology
Nalidixic Acid / therapeutic use*
Salmonella typhi / drug effects
Salmonella typhi / pathogenicity*
Survival Analysis
Typhoid Fever / drug therapy*
Typhoid Fever / mortality
Virulence*

Substances

Anti-Infective Agents
Nalidixic Acid